Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
34 hedge funds and large institutions have $45.5M invested in Histogen Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
+$11.1M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
+$9.32M |
| 3 |
Jennison Associates
New York
|
+$7.85M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.72M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$3.56M |
Top Sellers
HSTO Hedge Fund Activity: Q3 2013 in Review
34 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q3 2013, worth a combined $45.5M.
Buyers outnumbered sellers: 34 funds opened new HSTO positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was MPM Asset Management, opening a new position worth an estimated $11.1M.
- 34 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q3 2013, up from 0 in Q2 2013.
- Funds reported $45.5M of Histogen Inc. Common Stock stock for Q3 2013.
- 34 funds opened new Histogen Inc. Common Stock positions in Q3 2013 and 0 closed out, a net change of +34 holders.
- The largest Histogen Inc. Common Stock buyer in Q3 2013 was MPM Asset Management, an estimated $11.1M added.
Based on aggregated 13F filings for Q3 2013.